Abstract:Calcitonin gene-related peptide (CGRP) and nitric oxide (NO) have been recognized as important mediators in migraine but their mechanisms of action and interaction have not been fully elucidated. Monoclonal anti-CGRP antibodies like fremanezumab are successful preventives of frequent migraine and can be used to study CGRP actions in preclinical experiments. Fremanezumab (30 mg/kg) or an isotype control monoclonal antibody was subcutaneously injected to Wistar rats of both sexes. One to several days later, glyceroltrinitrate (GTN, 5 mg/kg) mimicking nitric oxide (NO) was intraperitoneally injected, either once or for three consecutive days. The trigeminal ganglia were removed to determine the concentration of CGRP using an enzyme-linked immunosorbent assay (ELISA). In one series of experiments, the animals were trained to reach an attractive sugar solution, the access to which could be limited by mechanical or thermal barriers. Using a semi-automated registration system, the frequency of approaches to the source, the residence time at the source, and the consumed solution were registered. The results were compared with previous data of rats not treated with GTN. The CGRP concentration in the trigeminal ganglia was generally higher in male rats and tended to be increased in animals treated once with GTN, whereas the CGRP concentration decreased after repetitive GTN treatment. No significant difference in CGRP concentration was observed between animals having received fremanezumab or the control antibody. Animals treated with GTN generally spent less time at the source and consumed less sugar solution. Without barriers, there was no significant difference between animals having received fremanezumab or the control antibody. Under mechanical barrier conditions, all behavioral parameters tended to be reduced but animals that had received fremanezumab tended to be more active, partly compensating for the depressive effect of GTN. In conclusion, GTN treatment seems to increase the production of CGRP in the trigeminal ganglion independently of the antibodies applied, but repetitive GTN administration may deplete CGRP stores. GTN treatment generally tends to suppress the animals' activity and increase facial sensitivity, which is partly compensated by fremanezumab through reduced CGRP signaling. If CGRP and NO signaling share the same pathway in sensitizing trigeminal afferents, GTN and NO may act downstream of CGRP to increase facial sensitivity.

Effects of Rizatriptan on Calcitonin Gene-Related Peptide, Proenkephalin and Cholecystokinin Mrna Expressions in the Trigeminal Ganglia of a Rat Migraine Model

Rizatriptan Effects on the Cholecystokinin Expression in Endogenous Pain Modulatory System of a Rat Mi-Graine Model

Effects of rizatriptan on the expression of calcitonin gene-related peptide and cholecystokinin in the periaqueductal gray of a rat migraine model.

Effects of rizatriptan on behavior and pain-related cytokines in peripheral blood of rat models with nitroglycerin-type migraine

Rizatriptan Benzoate Influences the Endogenous Pain Modulatory System in a Rat Model of Migraine.

Botulinum toxin type A for modulating calcitonin gene-related peptide contents in jugular plasma and brain stem of migraine model rats triggered by nitroglycerin

C-Jun N-Terminal Kinase Mediates Calcitonin Gene-Related Peptide Expression in Rat Trigeminal Ganglion in Vitro

C-Jun N-terminal kinase mediates calcitonin gene-related peptide expression in rat trigeminal ganglion in vitro | C-Jun N-Terminal Kinaz Si{dotless}çan Trigeminal Ganglionunda in Vitro Olarak Kalsitonin Gene-baǧli{dotless} Peptid Yapi{dotless}mi{dotless}ni{dotless} Düzenler

Effect of Xiongmatang Extract on Behavioral and TRPV1-CGRP/CGRP-R Pathway in Rats With Migraine

Sumatriptan down-regulates calcitonin gene-related peptide expression via extracellular signalregulated 1/2 and c-Jun N-terminal kinase signaling transduction pathways in rat trigeminal ganglion after organ culture

Effects of TNF-α, IL-1β and Sumatriptan on Calcitonin Gene-Related Peptide Mrna Expression in Rat Trigeminal Ganglion after Organ Culture

Effects of Toutongning Capsule on CGRP expression in the midbrain of rats with migraine headache model

Mitogen-Activated Protein Kinase Pathways are Involved in the Upregulation of Calcitonin Gene-Related Peptide of Rat Trigeminal Ganglion After Organ Culture

Effects of Duliang capsule on the expression of calcitonin gene-related peptide and cholecystokinin in the midbrain of a rat migraine model

Neuropeptide changes in an improved migraine model with repeat stimulations

Glycerol Trinitrate Acts Downstream of Calcitonin Gene-Related Peptide in Trigeminal Nociception—Evidence from Rodent Experiments with Anti-CGRP Antibody Fremanezumab

Behavioral study of a rat model of migraine induced by CGRP

Ghrelin attenuated hyperalgesia induced by chronic nitroglycerin: CGRP and TRPV1 as targets for migraine management

CGRP-dependent signalling pathways involved in mouse models of GTN- cilostazol- and levcromakalim-induced migraine

Comparative Efficacies of Antimigraine Drugs Using Nitroglycerin Induced Migraine Rats Model

Dynamic changes in CGRP, PACAP, and PACAP receptors in the trigeminovascular system of a novel repetitive electrical stimulation rat model: Relevant to migraine